Table 3. Validation of universal protocols.
Gene | Marker | No. of single cells tested | No. of heterozygotes | ADO (%) per locus | PCR efficiency (%) per locus | Positive blanks per locus |
---|---|---|---|---|---|---|
BRCA1 | D17S1814 | 57 | 54 | 1.8 | 96.5 | 0/13 |
D17S800 | 57 | 55 | 1.8 | 96.5 | 0/13 | |
D17S1787 | 57 | 55 | 1.8 | 96.5 | 0/13 | |
D17S932 | 57 | 55 | 1.8 | 96.5 | 0/13 | |
BRCA1_dis24AC | 57 | 55 | 0.0 | 96.5 | 1/13 | |
D17S950 | 57 | 54 | 0.0 | 96.5 | 0/13 | |
BRCA2 | D13S289 | 106 | 104 | 1.9 | 98.1 | 0/24 |
D13S260 | 106 | 69 | 5.8 | 98.1 | 0/24 | |
D13S1698 | 106 | 104 | 5.8 | 98.1 | 0/24 | |
BRCA2STR19 | 106 | 103 | 1.9 | 97.2 | 0/24 | |
D13S171 | 106 | 35 | 2.9 | 98.1 | 0/24 | |
D13S1695 | 106 | 34 | 0.0 | 97.2 | 1/24 | |
BRCA2_dist18AC | 106 | 70 | 0.0 | 97.2 | 0/24 | |
D13S267 | 106 | 69 | 0.0 | 98.1 | 0/24 |